Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | General Counsel and SVP | December 12, 2016 | December 16, 2016 |
| Erasca, Inc.ERAS · Entity 3796 | Chief Legal Officer | April 01, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date December 12, 2016 · Filed December 16, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - Restricted Stock UnitsSEC Table I · non-derivative | Direct | 48,545 |
Reported balance
After 2016-12-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-12 · Grant · Acquired 40,000 · Balance 48,545 F1: The RSUs vest annually with 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter. F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. F3: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. |
| Incentive Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2026-12-12 | Direct | 77,514 |
Reported balance
After 2016-12-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-12-12 · Grant · Acquired 40,000 · Balance 77,514 F5: Exercise price per share. F4: The options vest over four years with 25% vesting on the anniversary of the grant date and the remainder vesting in 36 installments each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSUs vest annually with 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock.
F3: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals.
F4: The options vest over four years with 25% vesting on the anniversary of the grant date and the remainder vesting in 36 installments each month thereafter.
F5: Exercise price per share.
Erasca, Inc.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,076 |
Ending reported balance
After 2026-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-01 · Exercise / conversion · Acquired 80,000 · Balance 105,076 F1: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Row 2 · 2026-04-01 · Sale · Disposed 80,000 · Balance 25,076 F1: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F2: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.58. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.70 · Expires 2034-02-04 | Direct | 280,000 |
Reported balance
After 2026-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-01 · Exercise / conversion · Disposed 80,000 · Balance 280,000 F1: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024.
F2: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.58. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC | Erasca, Inc. ERAS · Entity 3796 | Exercise / conversionStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · derivative · entry 3 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 80,000 shares Expires 2034-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC | Erasca, Inc. ERAS · Entity 3796 | SaleCommon Stock | 80,000 | $16.40 | $1,312,000.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F2 · price: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.58. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC | Erasca, Inc. ERAS · Entity 3796 | Exercise / conversionCommon Stock | 80,000 | $1.70 | $136,000.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 14:00 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock option (right to buy) · Derivative | 560,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030615 · ownership.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560,000 Underlying: Common Stock · 560,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:20 UTC | Erasca, Inc. ERAS · Entity 3796 | SaleCommon Stock | 120,000 | $5.59 | $670,812.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 3 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3 · price: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.80. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:20 UTC | Erasca, Inc. ERAS · Entity 3796 | Exercise / conversionCommon Stock | 120,000 | $1.70 | $204,000.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Read SEC document |
| December 15, 2025 Filed Jan 9, 2026 02:20 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantCommon Stock | 3,902 | $1.19 | $4,660.16 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F1 · price: The purchase price was calculated in accordance with the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 14:00 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-021831 · ownership.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-02-12 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 13, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 14:19 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock option (right to buy) · Derivative | 700,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-25-014194 · ownership.xml · derivative · entry 3 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2035-02-02 F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 07, 2025 Filed Jan 9, 2026 02:20 UTC | Erasca, Inc. ERAS · Entity 3796 | Exercise / conversionStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · derivative · entry 4 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 120,000 shares Expires 2034-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F4 · derivative.exercise_date: The shares subject to this option award are fully vested and exercisable as of the date hereof. Read SEC document |
| December 13, 2024 Filed Feb 5, 2025 14:19 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 5,731 | $1.56 | $8,963.28 |
DisclosureSEC source: 0000950170-25-014194 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,174 F1 · kind: Shares purchased under the Company's 2021 Employee Stock Purchase Plan F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. F3 · balance_after: Reflects all transactions reported under this report. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 12:50 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock Option (right to buy) · Derivative | 160,082 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-24-005926 · doc4.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,082 Underlying: Common Stock · 160,082 shares Expires 2034-06-19 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on June 20, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| June 14, 2024 Filed Feb 5, 2025 14:19 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 5,715 | $1.56 | $8,938.26 |
DisclosureSEC source: 0000950170-25-014194 · ownership.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,174 F1 · kind: Shares purchased under the Company's 2021 Employee Stock Purchase Plan F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. F3 · balance_after: Reflects all transactions reported under this report. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:50 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock Option (right to buy) · Derivative | 480,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001209191-24-002966 · doc4.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,000 Underlying: Common Stock · 480,000 shares Expires 2034-02-04 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 14:13 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 5,448 | $1.59 | $8,659.60 |
DisclosureSEC source: 0001209191-23-058910 · doc4.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,728 F1 · kind: Shares purchased under the issuer's 2021 Employee Stock Purchase Plan. F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 13:53 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock Option (right to buy) · Derivative | 480,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006479 · doc4.xml · derivative · entry 3 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,000 Underlying: Common Stock · 480,000 shares Expires 2033-01-31 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 13:53 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 2 | $3.89 | $7.79 |
DisclosureSEC source: 0001209191-23-006479 · doc4.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,280 F1 · balance_after: Includes 2,388 shares acquired under the Erasca, Inc. Employee Stock Purchase Plan (the ESPP) on June 15, 2022 and 2 shares acquired under the ESPP on December 15, 2022. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 13:53 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 2,388 | $4.10 | $9,783.64 |
DisclosureSEC source: 0001209191-23-006479 · doc4.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,280 F1 · balance_after: Includes 2,388 shares acquired under the Erasca, Inc. Employee Stock Purchase Plan (the ESPP) on June 15, 2022 and 2 shares acquired under the ESPP on December 15, 2022. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:56 UTC | Erasca, Inc. ERAS · Entity 3796 | GrantStock Option (Right to Buy) · Derivative | 171,110 | $0.00 Strike: $11.54 | $0.00 |
DisclosureSEC source: 0001209191-22-007069 · doc4.xml · derivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,110 Underlying: Common Stock · 171,110 shares Expires 2032-01-31 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following February 2, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:56 UTC | Erasca, Inc. ERAS · Entity 3796 | OtherCommon Stock | 990 | $11.60 | $11,486.48 |
DisclosureSEC source: 0001209191-22-007069 · doc4.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 F1 · balance_after: Includes 990 shares acquired under the Erasca, Inc. employee stock purchase plan on December 15, 2021. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 00:57 UTC | Erasca, Inc. ERAS · Entity 3796 | PurchaseCommon Stock | 900 | $16.00 | $14,400.00 |
DisclosureSEC source: 0000899243-21-029084 · doc4.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantIncentive Stock Option · Derivative | 40,000 | $4.43 Strike: $4.43 | $177,200.00 |
DisclosureSEC source: 0001350653-16-000127 · wf-form4_148191225949573.xml · derivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,514 Underlying: Common Stock · 40,000 shares Expires 2026-12-12 F5 · price: Exercise price per share. F4 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remainder vesting in 36 installments each month thereafter. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock - Restricted Stock Units | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001350653-16-000127 · wf-form4_148191225949573.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,545 F1 · security: The RSUs vest annually with 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter. F2 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. F3 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 22:14 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 322 | $1.94 | $624.04 |
DisclosureSEC source: 0001350653-16-000116 · wf-form4_147950727529781.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| November 15, 2016 Filed Dec 16, 2016 18:14 UTC Amendment | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 322 | $1.94 | $624.04 |
DisclosureSEC source: 0001350653-16-000118 · wf-form4a_148191207664218.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,545 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. F3 · balance_after: This amount was incorrectly listed as 8,250 in the original Form 4 filing. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.